These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

656 related items for PubMed ID: 25337205

  • 1. Insulin-like growth factor binding protein-1 inhibits cancer cell invasion and is associated with poor prognosis in hepatocellular carcinoma.
    Dai B, Ruan B, Wu J, Wang J, Shang R, Sun W, Li X, Dou K, Wang D, Li Y.
    Int J Clin Exp Pathol; 2014; 7(9):5645-54. PubMed ID: 25337205
    [Abstract] [Full Text] [Related]

  • 2. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
    Tu K, Dou C, Zheng X, Li C, Yang W, Yao Y, Liu Q.
    BMC Cancer; 2014 Dec 12; 14():938. PubMed ID: 25494879
    [Abstract] [Full Text] [Related]

  • 3. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
    Shi XM, Teng F.
    Int J Clin Exp Pathol; 2015 Dec 12; 8(4):4008-14. PubMed ID: 26097588
    [Abstract] [Full Text] [Related]

  • 4. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma.
    Cui X, Hu ZP, Li Z, Gao PJ, Zhu JY.
    World J Gastroenterol; 2015 Jul 28; 21(28):8588-604. PubMed ID: 26229401
    [Abstract] [Full Text] [Related]

  • 5. Identification of intragenic methylation in the TUSC1 gene as a novel prognostic marker of hepatocellular carcinoma.
    Shimizu D, Kanda M, Nomoto S, Oya H, Takami H, Hibino S, Suenaga M, Inokawa Y, Hishida M, Takano N, Nishikawa Y, Yamada S, Fujii T, Nakayama G, Sugimoto H, Koike M, Fujiwara M, Kodera Y.
    Oncol Rep; 2014 Mar 28; 31(3):1305-13. PubMed ID: 24366000
    [Abstract] [Full Text] [Related]

  • 6. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
    Wang G, Chen JH, Qiang Y, Wang DZ, Chen Z.
    World J Gastroenterol; 2015 Apr 07; 21(13):3983-93. PubMed ID: 25852285
    [Abstract] [Full Text] [Related]

  • 7. Reduced N-cadherin expression is associated with metastatic potential and poor surgical outcomes of hepatocellular carcinoma.
    Zhan DQ, Wei S, Liu C, Liang BY, Ji GB, Chen XP, Xiong M, Huang ZY.
    J Gastroenterol Hepatol; 2012 Jan 07; 27(1):173-80. PubMed ID: 21777276
    [Abstract] [Full Text] [Related]

  • 8. Loss of p57 expression and RhoA overexpression are associated with poor survival of patients with hepatocellular carcinoma.
    Hu T, Guo H, Wang W, Yu S, Han L, Jiang L, Ma J, Yang C, Guo Q, Nan K.
    Oncol Rep; 2013 Oct 07; 30(4):1707-14. PubMed ID: 23842948
    [Abstract] [Full Text] [Related]

  • 9. RRAD inhibits aerobic glycolysis, invasion, and migration and is associated with poor prognosis in hepatocellular carcinoma.
    Shang R, Wang J, Sun W, Dai B, Ruan B, Zhang Z, Yang X, Gao Y, Qu S, Lv X, Tao K, Wang L, Dou K, Wang D.
    Tumour Biol; 2016 Apr 07; 37(4):5097-105. PubMed ID: 26546438
    [Abstract] [Full Text] [Related]

  • 10. Overexpression of brachyury contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma.
    Du R, Wu S, Lv X, Fang H, Wu S, Kang J.
    J Exp Clin Cancer Res; 2014 Dec 14; 33(1):105. PubMed ID: 25499255
    [Abstract] [Full Text] [Related]

  • 11. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
    Chen D, Xing W, Hong J, Wang M, Huang Y, Zhu C, Yuan Y, Zeng W.
    Ann Surg Oncol; 2012 Oct 14; 19(11):3556-65. PubMed ID: 22588469
    [Abstract] [Full Text] [Related]

  • 12. Decreased expression of XPO4 is associated with poor prognosis in hepatocellular carcinoma.
    Liang XT, Pan K, Chen MS, Li JJ, Wang H, Zhao JJ, Sun JC, Chen YB, Ma HQ, Wang QJ, Xia JC.
    J Gastroenterol Hepatol; 2011 Mar 14; 26(3):544-9. PubMed ID: 21332550
    [Abstract] [Full Text] [Related]

  • 13. Cytohesin-2 as a novel prognostic marker for hepatocellular carcinoma.
    Xu K, Gao J, Yang X, Yao Y, Liu Q.
    Oncol Rep; 2013 Jun 14; 29(6):2211-8. PubMed ID: 23545718
    [Abstract] [Full Text] [Related]

  • 14. Overexpression of WAVE3 promotes tumor invasiveness and confers an unfavorable prognosis in human hepatocellular carcinoma.
    Ji Y, Li B, Zhu Z, Guo X, He W, Fan Z, Zhang W.
    Biomed Pharmacother; 2015 Feb 14; 69():409-15. PubMed ID: 25661390
    [Abstract] [Full Text] [Related]

  • 15. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1.
    Zhao XL, Sun T, Che N, Sun D, Zhao N, Dong XY, Gu Q, Yao Z, Sun BC.
    J Cell Mol Med; 2011 Mar 14; 15(3):691-700. PubMed ID: 20219012
    [Abstract] [Full Text] [Related]

  • 16. Down-regulation of formin-like 2 predicts poor prognosis in hepatocellular carcinoma.
    Liang L, Guan J, Zeng Y, Wang J, Li X, Zhang X, Ding Y.
    Hum Pathol; 2011 Nov 14; 42(11):1603-12. PubMed ID: 21496865
    [Abstract] [Full Text] [Related]

  • 17. A low level of GPR37 is associated with human hepatocellular carcinoma progression and poor patient survival.
    Liu F, Zhu C, Huang X, Cai J, Wang H, Wang X, He S, Liu C, Yang X, Zhang Y, Zhang T.
    Pathol Res Pract; 2014 Dec 14; 210(12):885-92. PubMed ID: 25169131
    [Abstract] [Full Text] [Related]

  • 18. S100A4 regulates migration and invasion in hepatocellular carcinoma HepG2 cells via NF-κB-dependent MMP-9 signal.
    Zhang J, Zhang DL, Jiao XL, Dong Q.
    Eur Rev Med Pharmacol Sci; 2013 Sep 14; 17(17):2372-82. PubMed ID: 24065232
    [Abstract] [Full Text] [Related]

  • 19. Down-regulated FSTL5 promotes cell proliferation and survival by affecting Wnt/β-catenin signaling in hepatocellular carcinoma.
    Zhang D, Ma X, Sun W, Cui P, Lu Z.
    Int J Clin Exp Pathol; 2015 Sep 14; 8(3):3386-94. PubMed ID: 26045876
    [Abstract] [Full Text] [Related]

  • 20. Overexpression of matrix metalloproteinase-12 (MMP-12) correlates with poor prognosis of hepatocellular carcinoma.
    Ng KT, Qi X, Kong KL, Cheung BY, Lo CM, Poon RT, Fan ST, Man K.
    Eur J Cancer; 2011 Oct 14; 47(15):2299-305. PubMed ID: 21683576
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.